Kaitlin Roberson
Founder
Cacti Therapeutics
Cacti is a biotech company developing FDA-approved Nociplastigens to treat chronic pain, inflammation, and opioid use disorder. By focusing on the psychological drivers of pain, Cacti aims to provide targeted therapies that improve patient outcomes and reduce reliance on opioids.
- Biotechnology
Updated 2 days ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- Cacti is a biotech company developing FDA-approved Nociplastigens to treat chronic pain, inflammation, and opioid use disorder. By focusing on the psychological drivers of pain, Cacti aims to provide targeted therapies that improve patient outcomes and reduce reliance on opioids.